RIPK1 and amyotrophic lateral sclerosis: TBK1 is an endogenous inhibitor of receptor‐interacting Ser/Thr protein kinase 1 (RIPK1) and an age‐related activation of RIPK1 is observed in TBK1‐ALS patients that leads neuroinflammation and neurodegeneration.165